Yahoo!   My Yahoo!   Mail  
Search   
Sign In
New User? Sign Up
Home > Investing > DRRX > Summary

Durect Corp.
(DRRX)

2.01USD   Up0.06 (3.08%)   
At 2:30AM IST
 Durect Corp. (NGM:DRRX) Delayed quote data 
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Last Trade: 2.01USD
Trade Time:2:30AM IST
Change:Up0.06 (3.08%)
Prev Close:1.95
Open:1.99
Bid:1.93 x 100
Ask:2.13 x 1000
1y Target Est:4.13
Day's Range:1.91 - 2.01
52wk Range:1.40 - 3.18
Volume:135,259
Avg Vol (3m):178,075
Market Cap:174.36M
P/E (ttm):N/A
EPS (ttm):-0.49
Div & Yield:N/A (N/A%)
Add DRRX to Portfolio   Download Data

HEADLINES

 
•DURECT CORP Files SEC form 8-K, Change in Directors or Principal Officers - EDGAR Online  - Fri, Jan 29
•DURECT CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits - EDGAR Online  - Wed, Jan 20
•DURECT Corporation Conference Call to Discuss POSIDUR Phase 3 Program scheduled for 11:00 am ET today - CCBN  - Tue, Jan 19
•DURECT Initiates U.S. Pivotal Phase III POSIDUR(TM) Clinical Trial - PR Newswire  - Tue, Jan 19
•Build Your Fortune With These Winners - Motley Fool  - Wed, Jan 6
•DURECT CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits - EDGAR Online  - Thu, Dec 17
•Durect: Pain anesthesia shows positive results - AP  - Thu, Dec 17
•DURECT Reports Positive Phase IIb Data from POSIDUR(TM) Clinical Program - PR Newswire  - Thu, Dec 17
•DURECT to Present at the 21st Annual Piper Jaffray Health Care Conference - PR Newswire  - Tue, Nov 24
•DURECT CORP Financials - EDGAR Online Financials  - Fri, Nov 6
» More Headlines for DRRX...

ANALYST

 
EPS Est (next year) (Dec-09) :-0.34
EPS Est (in 2 years) (Dec-10) :-0.30
Avg Rec (current)*:1.3
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
» Analyst Opinion» Estimates

BUSINESS SUMMARY

 
DURECT Corporation, a specialty pharmaceutical company, focuses on the development of pharmaceutical products for pain, central nervous system, disorders, cardiovascular disease, and other chronic diseases based on its proprietary drug formulation...

» Full Company Profile